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Introduction
Highly pathogenic avian influenza virus (H5N1) is the first 
avian influenza virus that documented to cause respiratory 
disease and death in human. The biological basis for the severe 
human disease and high fatality rate remains unclear. We have 
previously demonstrated that when compared to human H1N1 
and H3N2 influenza viruses, infection of influenza H5N1 virus 
led to the hyper-induction of pro-inflammatory cytokines in 
human primary macrophages and non-polarized respiratory 
epithelial cells in vitro. We also reported that patients with 
H5N1 disease have unusually high serum concentration of 
chemokines, e.g., IP-10. We therefore hypothesized that the 
differential hyper-induction of pro-inflammatory cytokines may 
contribute to the unusual severity of human H5N1 disease. In 
human, pathology of influenza A (H5N1) viruses are primarily 
respiratory pathogens targeting the respiratory epithelium, 
resulting in high level of cell death and tissue damage. As 
respiratory epithelial cells are primary target cells for replication 
of influenza viruses, a full understanding of how influenza virus 
interacts with respiratory epithelium is vital to advance our 
knowledge of its tropism and pathogenesis. 
Methods
Primary human respiratory (bronchial and alveolar) epithelial 
cells were isolated and seeded onto collagen-coated transwell 
filters and cultured under air-liquid interface until cells were 
polarized and differentiated. The replication kinetic of influenza 
virus was assessed by virus yield titration (TCID
50
) in MDCK cells. 
The cytokines expression profile induced by influenza H5N1 
viruses (A/HK/483/97 and A/Vietnam/3046/04) was compared 
with human H1N1 virus by quantitative RT-PCR and ELISA. 
Results
Polarized and differentiated bronchial and alveolar epithelial 
cells models are established for the study (Figure 1). We 
demonstrated that influenza A viruses (H5N1 and H1N1) can 
infect and productively replicate in the bronchial and alveolar 
epithelial cells leading to cytopathic effects. We found that the 
respiratory epithelial cells infected on the apical rather than 
the basolateral surface showed high levels of viral replication. 
Progeny influenza virus was released into the apical chamber 
at titers up to 3 logs higher than those recovered from the 
basolateral surface of polarized cell cultures (Figure 2). Influenza 
H5N1 viruses were more potent inducers of cytokines in human 
respiratory epithelial cells when compared to the H1N1 virus. 
We show that these cytokines are released preferentially at the 
basolateral aspect of the polarized epithelial cells (Figure 3). 
Conclusion
Our data suggest that influenza H5N1 viruses enter and are 
released from the apical domain of respiratory epithelium, 
while the pro-inflammatory cytokines are released preferentially 
from the basolateral aspect of the respiratory epithelium. These 
finding may provide important insights into the mechanism of 
replication and pathogenesis of influenza H5N1 virus in humans.
Figure 1. Polarized and differentiated bronchial and alveolar epithelial cells 
cultured at air-liquid interface using transwell inserts.  
Figure 2. Apical entry and release of influenza H5N1 virus in human respiratory 
epithelium. The replication kinetic of influenza virus infected through the Apical 
(▪) and Basolateral (▫) surface of the respiratory epithelium was assessed by virus 
yield Titration (TCID
50
/Ml) at 48 hours post infection. 
 
Figure 3. Basolateral release of proinflammatory cytokines induced by influenza 
(H5N1 and H1N1) viruses in human respiratory epithelium. IP-10 and RANTES 
were detected by ELISA from the cell supernatant collected from the Apical (A) 
and Basolateral (B) Surface of transwell inserts post infection.  
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Figure 2. Apical Entry and Release of Influenza H5N1 Virus in Human Respiratory Epithelium. The 
Replication Kinetic of Influenza Virus Infected Through the Apical ( ) and Basolateral (Ŀ) Surface of 
the Respiratory Epithelium Was Assessed by Virus Yield Titration (TCID50/Ml) at 48 Hours Post 
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Figure 3. Basolateral Release of Proinflammatory Cytokines Induced by Influenza (H5N1 and H1N1) 
Viruses in Human Respiratory Epithelium. IP-10 And RANTES Were Detected by ELISA From the 
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